sellModerate cluster of 310b5-1 plan
William Hoffman sold $3.3M of NARI
director at Inari Medical, Inc.. 60,000 shares at an average of $55.66, traded Dec 16, 2024, filed Dec 18, 2024.
Warning score
40Value
$3.3M
60,000 shares
Holdings after
441,233
-12% from before
From 52-week low
-
no price yet
From 52-week high
-
no price yet
Score components
- +15RoleDirector
- +25Trade size$3.3M at market
- +5Share of holdings soldSold 12% of holdings
- +15Cluster3 insiders selling within 14 days
- -2010b5-1 planPre-scheduled under a 10b5-1 plan
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Rows in this filing
Every transaction in Form 4 0001127602-24-029750, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Dec 16, 2024 | SOpen-market sale Common Stock10b5-1 | -3,176 | $54.33 | $173k | 498,057 | Dec 18, 2024 |
| Dec 16, 2024 | SOpen-market sale Common Stock10b5-1 | -20,917 | $55.23 | $1.2M | 477,140 | Dec 18, 2024 |
| Dec 16, 2024 | SOpen-market sale Common Stock10b5-1 | -13,560 | $56.45 | $765k | 463,580 | Dec 18, 2024 |
| Dec 16, 2024 | SOpen-market sale Common Stock10b5-1 | -2,347 | $56.82 | $133k | 461,233 | Dec 18, 2024 |
| Dec 16, 2024 | SOpen-market sale Common Stock10b5-1 | -2,100 | $54.42 | $114k | 459,133 | Dec 18, 2024 |
| Dec 16, 2024 | SOpen-market sale Common Stock10b5-1 | -10,301 | $55.27 | $569k | 448,832 | Dec 18, 2024 |
| Dec 16, 2024 | SOpen-market sale Common Stock10b5-1 | -7,467 | $56.51 | $422k | 441,365 | Dec 18, 2024 |
| Dec 16, 2024 | SOpen-market sale Common Stock10b5-1 | -132 | $56.89 | $7,509 | 441,233 | Dec 18, 2024 |
Related signals
Other insiders at Inari Medical, Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 30Weak | Inari Medical, Inc. | William Hoffman director | $12M 200,000 shares | -46% | |
| 31Weak | Inari Medical, Inc. | Andrew Hykes President and CEO | $166k 3,000 shares | -1% | |
| 22Weak | Inari Medical, Inc. | Thomas Tu Chief Medical Officer | $220k 4,000 shares | -1% | |
| 24Weak | Inari Medical, Inc. | Andrew Hykes President and CEO | $152k 3,000 shares | -1% | |
| 33Weak | Inari Medical, Inc. | William Hoffman director | $3.1M 60,000 shares | -11% | |
| 28Weak | Inari Medical, Inc. | William Hoffman director | $2.0M 40,000 shares | -7% | |
| 24Weak | Inari Medical, Inc. | Andrew Hykes President and CEO | $150k 3,000 shares | -1% | |
| 28Weak | Inari Medical, Inc. | William Hoffman director | $1.8M 40,000 shares | -6% | |
| 28Weak | Inari Medical, Inc. | William Hoffman director | $1.8M 40,000 shares | -6% | |
| 6Weak | Inari Medical, Inc. | Mitch C. Hill Chief Financial Officer | $135k 3,000 shares | -2% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.